Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model.

Clemens DL, Lee BY, Plamthottam S, Tullius MV, Wang R, Yu CJ, Li Z, Dillon BJ, Zink JI, Horwitz MA.

ACS Infect Dis. 2019 Feb 8;5(2):281-291. doi: 10.1021/acsinfecdis.8b00268. Epub 2018 Dec 10.

PMID:
30480992
2.

PPE37 Is Essential for Mycobacterium tuberculosis Heme-Iron Acquisition (HIA), and a Defective PPE37 in Mycobacterium bovis BCG Prevents HIA.

Tullius MV, Nava S, Horwitz MA.

Infect Immun. 2019 Jan 24;87(2). pii: e00540-18. doi: 10.1128/IAI.00540-18. Print 2019 Feb.

PMID:
30455201
3.

Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence.

Cunningham CR, Champhekar A, Tullius MV, Dillon BJ, Zhen A, de la Fuente JR, Herskovitz J, Elsaesser H, Snell LM, Wilson EB, de la Torre JC, Kitchen SG, Horwitz MA, Bensinger SJ, Smale ST, Brooks DG.

PLoS Pathog. 2016 Jan 25;12(1):e1005356. doi: 10.1371/journal.ppat.1005356. eCollection 2016 Jan.

4.
5.

Characterization of a Mycobacterium tuberculosis nanocompartment and its potential cargo proteins.

Contreras H, Joens MS, McMath LM, Le VP, Tullius MV, Kimmey JM, Bionghi N, Horwitz MA, Fitzpatrick JA, Goulding CW.

J Biol Chem. 2014 Jun 27;289(26):18279-89. doi: 10.1074/jbc.M114.570119. Epub 2014 May 22.

6.

Discovery and characterization of a unique mycobacterial heme acquisition system.

Tullius MV, Harmston CA, Owens CP, Chim N, Morse RP, McMath LM, Iniguez A, Kimmey JM, Sawaya MR, Whitelegge JP, Horwitz MA, Goulding CW.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5051-6. doi: 10.1073/pnas.1009516108. Epub 2011 Mar 7.

7.

A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG.

Tullius MV, Harth G, Maslesa-Galic S, Dillon BJ, Horwitz MA.

Infect Immun. 2008 Nov;76(11):5200-14. doi: 10.1128/IAI.00434-08. Epub 2008 Aug 25.

8.
9.
10.

Metabolic incorporation of unnatural sialic acids into Haemophilus ducreyi lipooligosaccharides.

Goon S, Schilling B, Tullius MV, Gibson BW, Bertozzi CR.

Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3089-94. Epub 2003 Mar 3.

11.

The lbgAB gene cluster of Haemophilus ducreyi encodes a beta-1,4-galactosyltransferase and an alpha-1,6-DD-heptosyltransferase involved in lipooligosaccharide biosynthesis.

Tullius MV, Phillips NJ, Scheffler NK, Samuels NM, Munson Jr RS Jr, Hansen EJ, Stevens-Riley M, Campagnari AA, Gibson BW.

Infect Immun. 2002 Jun;70(6):2853-61.

13.

Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi.

Sun S, Schilling B, Tarantino L, Tullius MV, Gibson BW, Munson RS Jr.

J Bacteriol. 2000 Apr;182(8):2292-8.

14.
16.
17.

Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms.

Melaugh W, Phillips NJ, Campagnari AA, Tullius MV, Gibson BW.

Biochemistry. 1994 Nov 8;33(44):13070-8.

PMID:
7947712

Supplemental Content

Loading ...
Support Center